Related Experiment Videos
Growth regulation of skin fibroblasts
1Department of Dermatology, Kanazawa University School of Medicine, 13-1 Takara-machl, 920-8641, Kanazawa, Japan. takehara@med.kanazawa-u.ac.jp
Abstract:
The growth of skin fibroblasts is regulated in a complex manner by various growth factors. Representative growth factors are platelet-derived growth factor (PDGF), basic fibroblast growth factor (b-FGF), transforming growth factor-beta (TGF-beta), and connective tissue growth factor (CTGF). These growth factors have various biological activities besides growth regulation of skin fibroblasts, and are involved in wound healing and in the pathogenesis of various disorders. For example, PDGF and CTGF stimulate chemotaxis of skin fibroblasts, b-FGF stimulates angiogenesis, and TGF-beta stimulates production of matrix proteins. First, the properties of these growth factors are reviewed briefly. Our skin fibrosis model in newborn mice are also described here. In 1986, Roberts et al. reported that subcutaneous injection of TGF-beta in newborn mice caused granulation tissue formation followed by fibrosis (Roberts et al. Proc Natl Acad Sci USA 1986;83:4167-71). We conducted similar experiments, and found that TGF-beta1, beta2 or beta3 caused skin fibrosis after 3 consecutive days of injection; this change was transient and disappeared after 7 consecutive days of injection. In contrast, irreversible fibrosis was observed upon stimultaneous injection of TGF-beta and b-FGF or TGF-beta and CTGF, or TGF-beta injection for the first 3 days and b-FGF or CTGF injection for the next 4 days (Shinozaki et al. Biochem Biophys Res Commun 1997;237:292-7; Mori et al. J Cell Physiol 1999;181:153-9). These observations suggest that TGF-beta induces skin fibrosis and b-FGF or CTGF maintains it in various skin fibrotic disorders. In the 21st century, we speculate that cocktails of various growth factors may permit subtle growth regulation of skin fibroblasts; such technology would have applications in the treatment of many skin diseases.
Insights
Transforming growth factor-beta (TGF-beta) induces transient skin fibrosis in mice, but combining it with basic fibroblast growth factor (b-FGF) or connective tissue growth factor (CTGF) leads to irreversible fibrosis, suggesting a maintenance role for these factors in fibrotic disorders.
Area of Science:
- Dermatology
- Molecular Biology
- Wound Healing Research
Background:
- Skin fibroblast growth is complexly regulated by growth factors like platelet-derived growth factor (PDGF), basic fibroblast growth factor (b-FGF), transforming growth factor-beta (TGF-beta), and connective tissue growth factor (CTGF).
- These factors influence wound healing and various pathological conditions, with specific roles in fibroblast chemotaxis, angiogenesis, and matrix protein production.
Purpose of the Study:
- To investigate the role of TGF-beta, b-FGF, and CTGF in inducing and maintaining skin fibrosis.
- To explore the potential of growth factor combinations in regulating skin fibroblast behavior for therapeutic applications.
Main Methods:
- Induction of skin fibrosis in newborn mice through subcutaneous injections of TGF-beta, b-FGF, and CTGF, individually and in combination.
- Observation and assessment of fibrotic changes over consecutive days of injection.
Main Results:
- TGF-beta (isoforms 1, 2, or 3) induced transient skin fibrosis after 3 days, which resolved after 7 days of continuous injection.
- Irreversible skin fibrosis was observed when TGF-beta was co-injected with either b-FGF or CTGF, or when TGF-beta was followed by b-FGF or CTGF injections.
- These findings suggest TGF-beta initiates fibrosis, while b-FGF or CTGF sustains it.
Conclusions:
- TGF-beta is a key inducer of skin fibrosis.
- b-FGF and CTGF play a crucial role in maintaining TGF-beta-induced skin fibrosis.
- Future research may focus on growth factor cocktails for precise regulation of skin fibroblasts in treating skin diseases.